Logo image of ZJYL

JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Price, Quote, News and Overview

NASDAQ:ZJYL - Nasdaq - KYG5140V1124 - Common Stock - Currency: USD

0.7639  -0.03 (-3.79%)

After market: 0.77 +0.01 (+0.8%)

ZJYL Quote, Performance and Key Statistics

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (2/21/2025, 8:00:02 PM)

After market: 0.77 +0.01 (+0.8%)

0.7639

-0.03 (-3.79%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High11.15
52 Week Low0.7
Market Cap119.59M
Shares156.55M
Float37.82M
Yearly DividendN/A
Dividend YieldN/A
PE38.2
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-28 2023-03-28


ZJYL short term performance overview.The bars show the price performance of ZJYL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

ZJYL long term performance overview.The bars show the price performance of ZJYL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ZJYL is 0.7639 USD. In the past month the price decreased by -13.09%. In the past year, price decreased by -89.23%.

JIN MEDICAL INTERNATIONAL LT / ZJYL Daily stock chart

ZJYL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About ZJYL

Company Profile

ZJYL logo image Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company is headquartered in Changzhou, Jiangsu and currently employs 245 full-time employees. The company went IPO on 2023-03-28. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The firm's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The firm mainly distributes its products in domestic and overseas markets.

Company Info

JIN MEDICAL INTERNATIONAL LT

No. 33 Lingxiang Road, Wujin District

Changzhou JIANGSU CN

Employees: 245

Company Website: http://ir.zhjmedical.com/

Investor Relations: http://ir.zhjmedical.com/

Phone: 8651989607972

JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ

What is the stock price of JIN MEDICAL INTERNATIONAL LT today?

The current stock price of ZJYL is 0.7639 USD. The price decreased by -3.79% in the last trading session.


What is the ticker symbol for JIN MEDICAL INTERNATIONAL LT stock?

The exchange symbol of JIN MEDICAL INTERNATIONAL LT is ZJYL and it is listed on the Nasdaq exchange.


On which exchange is ZJYL stock listed?

ZJYL stock is listed on the Nasdaq exchange.


What is JIN MEDICAL INTERNATIONAL LT worth?

JIN MEDICAL INTERNATIONAL LT (ZJYL) has a market capitalization of 119.59M USD. This makes ZJYL a Micro Cap stock.


How many employees does JIN MEDICAL INTERNATIONAL LT have?

JIN MEDICAL INTERNATIONAL LT (ZJYL) currently has 245 employees.


What are the support and resistance levels for JIN MEDICAL INTERNATIONAL LT (ZJYL) stock?

JIN MEDICAL INTERNATIONAL LT (ZJYL) has a support level at 0.71 and a resistance level at 0.84. Check the full technical report for a detailed analysis of ZJYL support and resistance levels.


Should I buy JIN MEDICAL INTERNATIONAL LT (ZJYL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does JIN MEDICAL INTERNATIONAL LT (ZJYL) stock pay dividends?

ZJYL does not pay a dividend.


What is the Price/Earnings (PE) ratio of JIN MEDICAL INTERNATIONAL LT (ZJYL)?

The PE ratio for JIN MEDICAL INTERNATIONAL LT (ZJYL) is 38.2. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 0.7639 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZJYL.


What is the Short Interest ratio of JIN MEDICAL INTERNATIONAL LT (ZJYL) stock?

The outstanding short interest for JIN MEDICAL INTERNATIONAL LT (ZJYL) is 2.17% of its float. Check the ownership tab for more information on the ZJYL short interest.


ZJYL Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ZJYL. When comparing the yearly performance of all stocks, ZJYL is a bad performer in the overall market: 97.41% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ZJYL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ZJYL. ZJYL has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZJYL Financial Highlights

Over the last trailing twelve months ZJYL reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS decreased by -37.83% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.44%
ROA 7.06%
ROE 11.07%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%-12.17%
Sales Q2Q%2.96%
EPS 1Y (TTM)-37.83%
Revenue 1Y (TTM)-31.65%

ZJYL Ownership and Analysts


Ownership
Inst Owners1.23%
Ins OwnersN/A
Short Float %2.17%
Short Ratio2.14
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A